Takeda’s new study data for oveporexton shows improvements in narcolepsy type 1
The phase 3 results show improvements in daily function, cognition and nighttime sleep
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Takeda’s new study data for oveporexton shows improvements in narcolepsy type 1
The phase 3 results show improvements in daily function, cognition and nighttime sleep
Lilly to acquire LimmaTech Biologics and Vaccine Company in deals totalling $2.33bn
The acquisitions reinforce the company’s commitment to reduce the long-term burden of serious disease
Gilead’s New Drug Application for Yeztugo accepted by US FDA
The investigational once-weekly oral treatment could be the first long-acting pill for HIV prevention
EMA celebrates diversity and inclusion in science and healthcare
The EU body underlines its commitment to diverse perspectives in medicines regulation
PMEA welcome Simon Bates as new Chair of the judging panel
Roche and Alnylam share their experiences entering the PMEAs
Latest content
Broken String Biosciences appoints Bruce Eaton as Chairman of the Board
Eaton specialises in strategic planning, organisational leadership and commercial execution
Read More
Fondazione Telethon appoints Graciana Diez-Roux as new Scientific Director
Diez-Roux will lead the Foundation’s scientific activities in rare genetic disease research
Read More
Oriva Therapeutics appoints Agnès Arbat as CEO
Arbat previously held senior roles in women’s health at Oxolife, Bayer and Organon
Read More
Ardena appoints Ariane de Ganck as Chief Scientific Officer
de Ganck was previously lead of the company’s Drug Product division
Read More
Intelligence
Bridging the gap between European brain innovation and real-world policy
Aligning policy and public funding strategies to support brain health across Europe
Read More
Obesity care in the UK – why it can’t improve until it is recognised as a disease
The WHO classified obesity as a chronic disease over twenty years ago – but UK policy has yet to follow
Read More
The next frontier in clinical trials: navigating multi-disease research with GLP-1s
As GLP-1s redefine the treatment landscape for obesity, they are also promising candidates to influence a wide range of disease pathways
Read More
Headline trade and market deals are opening doors to greater patient access
Regulatory changes and tariffs have created a positive climate for investment, innovation and, critically, patient access to therapies
Read More
Men’s health: the gap between awareness and action is where men’s lives are lost
Until the gap between what healthcare systems can offer and how men actually engage with them is closed, outcomes will continue to deteriorate
Read More
The digital age and the advance of AI – pushing communications to new heights
As new comms excellence opportunities abound, staying connected through core messaging remains critical
Read More
Blogs
Latest
J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment
June 17, 2026 | Uniphar|
Strategic partnership enables direct progression to Phase 3, bypassing additional Phase 2 study, as first patients are randomized in global trial TOKYO, Japan and DUBLIN, Ireland — …
Medscape Education Recognized With 2 Spring 2026 Digital Health Awards for Excellence in Clinical Education
June 16, 2026 | Medscape Education|
Medscape Education has been recognized with 2 prestigious accolades at the Spring 2026 Digital Health Awards. The premier digital education platform earned a Gold Award …
New benchmark reveals significant digital maturity gap across UK POM companies’ product-information estates
June 11, 2026 | Genetic Digital|ABPI, Digital, Pharma, Website, compliance, digital estate, digital marketing, emc, pom, prescription only medicines
A new benchmark maps 100 UK prescription medicine companies across five maturity bands and finds a market at very different stages of digital development
The words around health matter
June 4, 2026 | Mednet|Language choices, Making Health Whole, healthcare communications, healthcare innovation, medcomms
The language used in healthcare can influence how people perceive their health, feel about themselves, and engage with treatments. Whole-person communication can help reduce stigma …
Medscape Education Brings AI to the Hematology Frontline at EHA 2026
June 2, 2026 | Medscape Education|AI, EHA, EHACongress26, Symposia, heamatology, hematology
Medscape Education is supporting a dedicated AI symposium at the 2026 European Hematology Association (EHA) Annual Congress in Stockholm on June 11, 2026.
Healthcare information is becoming easier to access. Trust isn’t.
June 17, 2026 | Cuttsy + Cuttsy|AI, Communications, Digital, health literacy
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment
June 17, 2026 | Cuttsy + Cuttsy|ASCO2026, clinical trials
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.
How to build a commercialisation strategy fit for biopharma’s new evidence era
June 11, 2026 | Nmblr|
The bar for evidence has never been higher. The EU’s Joint Clinical Assessment process went live in January 2025, introducing harmonised clinical evidence requirements across …
Where translation falls short in practice
June 10, 2026 | Cuttsy + Cuttsy|Localisation, clinical trial, translation
Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.
From activity to impact: 5 takeaways from MAPS Americas 2026
June 2, 2026 | Inizio|
Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed …